Login to Your Account



How INFORM-1 May Change HCV Drug Development

By Trista Morrison


Monday, May 4, 2009
At last week's 44th annual meeting of the European Association for the Study of the Liver (EASL), all eyes were on preliminary data from INFORM-1, the first study to combine two direct-acting antivirals for hepatitis C. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription